Anti-cancer activity screening results.

Compounds	Cell viability (%) ±SD
	MCF-7			MDA-MB-453			MCF-10A
	25 μM	10 μM	1 μM	25 μM	10 μM	1 μM	25 μM	50 μM	100 μM
23	31.7 ± 4.0	40.3 ± 3.6	66.7 ± 1.18	77.1 ± 5.7	88.4 ± 5.4	80.6 ± 8.0	88.6 ± 1.5	86.3 ± 2.9	84.2 ± 3.0
26	52.8 ± 3.0	65.8 ± 1.8	80.0 ± 4.5	66.3 ± 5.8	84.2 ± 11.5	87.8 ± 3.2	87.8 ± 2.8	85.6 ± 0.7	82.0 ± 1.5
30	42.3 ± 7.6	57.7 ± 2.4	78.2 ± 2.6	61.4 ± 3.2	74.8 ± 1.5	99.2 ± 8.1	86.8 ± 5.3	84.8 ± 3.0	78.5 ± 3.4
33	25.0 ± 2.9	35.0 ± 2.5	67.0 ± 4.7	67.6 ± 5.3	78.3 ± 4.7	88.8 ± 5.2	99.6 ± 2.2	87.6 ± 1.7	81.4 ± 2.6
36	28.1 ± 4.4	32.4 ± 0.9	52.3 ± 3.1	63.8 ± 1.7	82.9 ± 1.2	91.5 ± 4.6	88.6 ± 1.5	86.1 ± 2.8	84.2 ± 3.0
41	48.1 ± 3.5	58.2 ± 3.8	72.8 ± 4.2	95.1 ± 35.7	77.4 ± 5.4	96.4 ± 4.8	89.8 ± 2.8	84.2 ± 5.8	83.0 ± 1.5
YM155 (20 nM)	31.2 ± 1.7	31.2 ± 1.7	31.2 ± 1.7	36.2 ± 1.5	36.2 ± 1.5	36.2 ± 1.5	39.2 ± 1.6	39.2 ± 1.6	39.2 ± 1.6